BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Senichkin VV, Streletskaia AY, Gorbunova AS, Zhivotovsky B, Kopeina GS. Saga of Mcl-1: regulation from transcription to degradation. Cell Death Differ 2020;27:405-19. [PMID: 31907390 DOI: 10.1038/s41418-019-0486-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Bourafai-Aziez A, Benabderrahmane M, Paysant H, Weiswald LB, Poulain L, Carlier L, Ravault D, Jouanne M, Coadou G, Oulyadi H, Voisin-Chiret AS, Sopková-de Oliveira Santos J, Sebban M. Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1. Drug Des Devel Ther 2021;15:5035-59. [PMID: 34949914 DOI: 10.2147/DDDT.S323077] [Reference Citation Analysis]
2 Wang H, Wang X, Wang W, Chai W, Song W, Zhang H, Mou W, Pei M, Su Y, Ma X, Gui J. Interleukin-15 enhanced the survival of human γδT cells by regulating the expression of Mcl-1 in neuroblastoma. Cell Death Discov 2022;8. [DOI: 10.1038/s41420-022-00942-5] [Reference Citation Analysis]
3 Senichkin VV, Pervushin NV, Zuev AP, Zhivotovsky B, Kopeina GS. Targeting Bcl-2 Family Proteins: What, Where, When? Biochemistry (Mosc) 2020;85:1210-26. [PMID: 33202206 DOI: 10.1134/S0006297920100090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
4 Inde Z, Forcina GC, Denton K, Dixon SJ. Kinetic Heterogeneity of Cancer Cell Fractional Killing. Cell Rep 2020;32:107845. [PMID: 32640215 DOI: 10.1016/j.celrep.2020.107845] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Streletskaia AY, Senichkin VV, Prikazchikova TA, Zatsepin TS, Zhivotovsky B, Kopeina GS. Upregulation of Mcl-1S Causes Cell-Cycle Perturbations and DNA Damage Accumulation. Front Cell Dev Biol 2020;8:543066. [PMID: 33072738 DOI: 10.3389/fcell.2020.543066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Piacentini M, Shi Y, Simon HU. 10 years of Cell Death & Disease. Cell Death Dis 2020;11:1064. [PMID: 33311494 DOI: 10.1038/s41419-020-03287-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Choi HS, Baek KH. Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes. Cell Mol Life Sci 2022;79:117. [PMID: 35118522 DOI: 10.1007/s00018-022-04132-5] [Reference Citation Analysis]
8 Morgan EL, Patterson MR, Barba-Moreno D, Scarth JA, Wilson A, Macdonald A. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer. Oncogene 2021;40:2112-29. [PMID: 33627786 DOI: 10.1038/s41388-021-01679-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Slomp A, Moesbergen LM, Eldering E, Kersten MJ, Minnema MC, Peperzak V. Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells. Cell Death Dis 2021;12:229. [PMID: 33658484 DOI: 10.1038/s41419-020-03351-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Winder ML, Campbell KJ. MCL-1 is a clinically targetable vulnerability in breast cancer. Cell Cycle 2022;:1-17. [PMID: 35349392 DOI: 10.1080/15384101.2022.2054096] [Reference Citation Analysis]
11 Shimizu K, Gi M, Suzuki S, North BJ, Watahiki A, Fukumoto S, Asara JM, Tokunaga F, Wei W, Inuzuka H. Interplay between protein acetylation and ubiquitination controls MCL1 protein stability. Cell Rep 2021;37:109988. [PMID: 34758305 DOI: 10.1016/j.celrep.2021.109988] [Reference Citation Analysis]
12 Sancho M, Leiva D, Lucendo E, Orzáez M. Understanding MCL1: from cellular function and regulation to pharmacological inhibition. FEBS J 2021. [PMID: 34310025 DOI: 10.1111/febs.16136] [Reference Citation Analysis]
13 Chin HS, Fu NY. Physiological Functions of Mcl-1: Insights From Genetic Mouse Models. Front Cell Dev Biol 2021;9:704547. [PMID: 34336857 DOI: 10.3389/fcell.2021.704547] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Mittal P, Singh S, Sinha R, Shrivastava A, Singh A, Singh IK. Myeloid cell leukemia 1 (MCL-1): Structural characteristics and application in cancer therapy. Int J Biol Macromol 2021;187:999-1018. [PMID: 34339789 DOI: 10.1016/j.ijbiomac.2021.07.166] [Reference Citation Analysis]
15 Al-Odat O, von Suskil M, Chitren R, Elbezanti W, Srivastava S, Budak-Alpddogan T, Jonnalagadda S, Aggarwal B, Pandey M. Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma. Front Pharmacol 2021;12:699629. [PMID: 34349655 DOI: 10.3389/fphar.2021.699629] [Reference Citation Analysis]
16 You KS, Yi YW, Cho J, Park JS, Seong YS. Potentiating Therapeutic Effects of Epidermal Growth Factor Receptor Inhibition in Triple-Negative Breast Cancer. Pharmaceuticals (Basel) 2021;14:589. [PMID: 34207383 DOI: 10.3390/ph14060589] [Reference Citation Analysis]
17 Chiou JT, Huang CH, Wu TH, Wang LJ, Lee YC, Huang PW, Chang LS. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Toxicol Appl Pharmacol 2021;435:115847. [PMID: 34963561 DOI: 10.1016/j.taap.2021.115847] [Reference Citation Analysis]
18 Sarif Z, Tolksdorf B, Fechner H, Eberle J. Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells. Mol Carcinog 2020;59:1256-68. [PMID: 32885857 DOI: 10.1002/mc.23253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Kurschat C, Metz A, Kirschnek S, Häcker G. Importance of Bcl-2-family proteins in murine hematopoietic progenitor and early B cells. Cell Death Dis 2021;12:784. [PMID: 34381022 DOI: 10.1038/s41419-021-04079-8] [Reference Citation Analysis]
20 Della-Morte D, Pacifici F, Ricordi C, Massoud R, Rovella V, Proietti S, Iozzo M, Lauro D, Bernardini S, Bonassi S, Di Daniele N. Low level of plasminogen increases risk for mortality in COVID-19 patients. Cell Death Dis 2021;12:773. [PMID: 34354045 DOI: 10.1038/s41419-021-04070-3] [Reference Citation Analysis]
21 Pollak N, Lindner A, Imig D, Kuritz K, Fritze JS, Decker L, Heinrich I, Stadager J, Eisler S, Stöhr D, Allgöwer F, Scheurich P, Rehm M. Cell cycle progression and transmitotic apoptosis resistance promote escape from extrinsic apoptosis. J Cell Sci 2021;134:jcs258966. [PMID: 34806752 DOI: 10.1242/jcs.258966] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Pervushin NV, Senichkin VV, Kapusta AA, Gorbunova AS, Kaminskyy VO, Zhivotovsky B, Kopeina GS. Nutrient Deprivation Promotes MCL-1 Degradation in an Autophagy-Independent Manner. Biochemistry (Mosc) 2020;85:1235-44. [PMID: 33202208 DOI: 10.1134/S0006297920100119] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Mammarella E, Zampieri C, Panatta E, Melino G, Amelio I. NUAK2 and RCan2 participate in the p53 mutant pro-tumorigenic network. Biol Direct 2021;16:11. [PMID: 34348766 DOI: 10.1186/s13062-021-00296-5] [Reference Citation Analysis]
24 Moyzis AG, Lally NS, Liang W, Najor RH, Gustafsson ÅB. Mcl-1 Differentially Regulates Autophagy in Response to Changes in Energy Status and Mitochondrial Damage. Cells 2022;11:1469. [DOI: 10.3390/cells11091469] [Reference Citation Analysis]
25 Ganini C, Amelio I, Bertolo R, Bove P, Buonomo OC, Candi E, Cipriani C, Di Daniele N, Juhl H, Mauriello A, Marani C, Marshall J, Melino S, Marchetti P, Montanaro M, Natale ME, Novelli F, Palmieri G, Piacentini M, Rendina EA, Roselli M, Sica G, Tesauro M, Rovella V, Tisone G, Shi Y, Wang Y, Melino G. Global mapping of cancers: The Cancer Genome Atlas and beyond. Mol Oncol 2021. [PMID: 34245122 DOI: 10.1002/1878-0261.13056] [Reference Citation Analysis]
26 Ali A, Kulik G. Signaling Pathways That Control Apoptosis in Prostate Cancer. Cancers (Basel) 2021;13:937. [PMID: 33668112 DOI: 10.3390/cancers13050937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Widden H, Placzek WJ. The multiple mechanisms of MCL1 in the regulation of cell fate. Commun Biol 2021;4:1029. [PMID: 34475520 DOI: 10.1038/s42003-021-02564-6] [Reference Citation Analysis]
28 Dutta I, Dieters-Castator D, Papatzimas JW, Medina A, Schueler J, Derksen DJ, Lajoie G, Postovit LM, Siegers GM. ADAM protease inhibition overcomes resistance of breast cancer stem-like cells to γδ T cell immunotherapy. Cancer Lett 2021;496:156-68. [PMID: 33045304 DOI: 10.1016/j.canlet.2020.10.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Huang C, Lee Y, Chiou J, Shi Y, Wang L, Chang L. Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicology and Applied Pharmacology 2020;397:115013. [DOI: 10.1016/j.taap.2020.115013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Klener P, Sovilj D, Renesova N, Andera L. BH3 Mimetics in Hematologic Malignancies. Int J Mol Sci 2021;22:10157. [PMID: 34576319 DOI: 10.3390/ijms221810157] [Reference Citation Analysis]
31 Tan Y, Li T, Hu M, Wang B, Zhou Q, Jiang Y, Zhang S, Duan X, Yang J, Liu X, Zhan Z. PHLPP1 deficiency ameliorates cardiomyocyte death and cardiac dysfunction through inhibiting Mcl-1 degradation. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110281] [Reference Citation Analysis]
32 Pervushin NV, Senichkin VV, Zhivotovsky B, Kopeina GS. Mcl-1 as a "barrier" in cancer treatment: Can we target it now? Int Rev Cell Mol Biol 2020;351:23-55. [PMID: 32247581 DOI: 10.1016/bs.ircmb.2020.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Basu-Shrivastava M, Kozoriz A, Desagher S, Lassot I. To Ubiquitinate or Not to Ubiquitinate: TRIM17 in Cell Life and Death. Cells 2021;10:1235. [PMID: 34069831 DOI: 10.3390/cells10051235] [Reference Citation Analysis]
34 Sun L, Jiang Y, Yan X, Dai X, Huang C, Chen L, Li T, Zhang Y, Xiao H, Yang M, Xiang L, Zhang Y, Chen S, Li S, Chen A, He F, Lian J. Dichloroacetate enhances the anti-tumor effect of sorafenib via modulating the ROS-JNK-Mcl-1 pathway in liver cancer cells. Exp Cell Res 2021;406:112755. [PMID: 34332981 DOI: 10.1016/j.yexcr.2021.112755] [Reference Citation Analysis]
35 Yu X, Gao F, Li W, Zhou L, Liu W, Li M. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer. J Exp Clin Cancer Res 2020;39:62. [PMID: 32276600 DOI: 10.1186/s13046-020-01566-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
36 Choi SJ, Swarup N, Shin JA, Hong SD, Cho SD. Myeloid cell leukemia-1 expression in cancers of the oral cavity: a scoping review. Cancer Cell Int 2022;22:182. [PMID: 35524332 DOI: 10.1186/s12935-022-02603-0] [Reference Citation Analysis]
37 Bolomsky A, Vogler M, Köse MC, Heckman CA, Ehx G, Ludwig H, Caers J. MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents. J Hematol Oncol 2020;13:173. [PMID: 33308268 DOI: 10.1186/s13045-020-01007-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
38 Liao WH, Song XQ, Kong YJ, Bao RD, Li FF, Zhou J, Zhao QH, Xu JY, Xie N, Xie MJ. A novel Schiff base cobalt(III) complex induces a synergistic effect on cervical cancer cells by arresting early apoptosis stage. Biometals 2021;34:277-89. [PMID: 33389333 DOI: 10.1007/s10534-020-00278-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wattanathamsan O, Thararattanobon R, Rodsiri R, Chanvorachote P, Vinayanuwattikun C, Pongrakhananon V. Tubulin acetylation enhances lung cancer resistance to paclitaxel-induced cell death through Mcl-1 stabilization. Cell Death Discov 2021;7:67. [PMID: 33824297 DOI: 10.1038/s41420-021-00453-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Lee YC, Wang LJ, Huang CH, Chiou JT, Shi YJ, Chang LS. Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation. Biochem Pharmacol 2020;178:114047. [PMID: 32446890 DOI: 10.1016/j.bcp.2020.114047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Moyzis AG, Lally NS, Liang W, Leon LJ, Najor RH, Orogo AM, Gustafsson ÅB. Mcl-1-mediated mitochondrial fission protects against stress but impairs cardiac adaptation to exercise. J Mol Cell Cardiol 2020;146:109-20. [PMID: 32717194 DOI: 10.1016/j.yjmcc.2020.07.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
42 Tang Y, Yang Y, Luo J, Liu S, Zhan Y, Zang H, Zheng H, Zhang Y, Feng J, Fan S, Wen Q. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients. Cancer Biomark 2021;30:85-94. [PMID: 32986659 DOI: 10.3233/CBM-200410] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Hino M, Iemura K, Ikeda M, Itoh G, Tanaka K. Chromosome alignment-maintaining phosphoprotein CHAMP1 plays a role in cell survival through regulating Mcl-1 expression. Cancer Sci 2021;112:3711-21. [PMID: 34107118 DOI: 10.1111/cas.15018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]